Categories Consumer
New Age Beverages stock jumps after its announcement of $85-mln Morinda acquisition
New Age Beverages Corp. (Nasdaq: NBEV) acquires Tahitian Noni Juice maker Morinda Holdings for $85 million. The combined company would be the 40th largest non-alcoholic beverage company in the world with $300 million in net revenue $20 million in adjusted EBITDA, $200 million in assets and no debt. NBEV stock jumped up about 15% when the market opened today, but later pared the gains.
The Colorado-based beverage company will spend $50 million ($75 million in cash and $10 million in stock) for this transaction, which is expected to close in the late December. The cash consideration for the transaction will be sourced from New Age’s current cash balance.
The combination is expected to expand New Age Beverages’ healthy beverages portfolio. More than $10 million of potential cost and revenue synergies have been identified and are expected to be gained over the next 12 to 18 months.
After the initial cheer, New Age Beverages experience a hangover
The Utah-based Morinda’s business is primarily a monthly subscriber-based model, fulfilled by a worldwide manufacturing and distribution network that includes owned and outsourced production in the US, Germany, Tahiti, Japan and China. More than 70% of its business is generated in the key Asia Pacific markets of Japan, China, Korea, Taiwan, and Indonesia.
In Q3 earnings conference call, the company had stated that working capital will be used in the future on its core business and CBD and health sciences businesses, and for targeted external growth opportunities like alliances or acquisitions.
New Age Beverages will conduct a conference call on Tuesday at 8:30 am ET to discuss further about this transaction.
New Age stock has surged about 125% and it has been trading in the range of $1.30 to $9.99 in the past one year.
We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments